WHO WE WORK WITH
We work with healthcare leaders navigating critical inflection points.
FOR INVESTOrs
Investors do not struggle to find innovation.
They struggle to filter execution readiness.
Without a shared language for commercialization maturity, deal filters become subjective, misalignment goes unnamed, and portfolio support is reactive instead of strategic.
THE FRICTION
We implement the MCG Commercial Readiness Framework and diagnostic Scorecard to create a consistent standard for evaluating readiness across your pipeline and portfolio.
When commercialization gaps surface, we build the capabilities required to mitigate risk and protect capital.
HOW MCG SOLVES IT
Phase-based Commercial Readiness assessment
Diligence support focused on commercial sequencing risk
Portfolio company assessment and alignment strategy
Ongoing advisory for portfolio companies or funds navigating inflection points
WHAT WE PROVIDE
FOR FOUNDERS & EXECUTIVE TEAMS
Founders rarely hear a clear no.
More often, they hear: “Too early.”, “Not in our thesis.”, “Come back when you have traction.”
Without a shared readiness standard, that feedback is hard to operationalize. Teams continue building, but sequencing risk goes unnamed.
Commercialization and adoption risk are often deferred behind product, regulatory, or capital milestones. When they surface, correction is costly and credibility is already on the line.
THE FRICTION
We bring a structured readiness standard to your growth strategy.
The MCG Framework and Scorecard identify sequencing gaps early and translate feedback into clear execution priorities.
Where capabilities fall short, we work alongside leadership to close gaps before capital and market scrutiny intensify.
HOW MCG SOLVES IT
Phase-based Commercial Readiness assessment
Sequencing and commercialization roadmap
GTM and access alignment strategy
Advisory support during inflection points and fundraising cycles
WHAT WE PROVIDE
FEEDBACK ON THE MCG COMMERCIALIZATION FRAMEWORK
“The way it [the Framework] surfaces misalignment between scientific progress, capital expectations, and execution realities maps closely to what we see in diligence and post-investment.”
— Private Equity Healthcare Investor“This is an insightful document, and the experience of those who built it is quite evident in the roadmap. Companies rarely map these steps perfectly. It's a good guide and provoked thought on my part.”
— Series B Medtech Founder & CEO“Commercial readiness is one of the biggest unmet needs in early-stage healthcare. The hard part is helping founders see it before investors do.”
— Venture Capital Healthcare Investor
